Publications

BMC gastroenterology

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study.

16-08-2019

BMJ open

Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).

27-07-2019

Nature

Genome-wide cell-free DNA fragmentation in patients with cancer.

01-06-2019

BMC cancer

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6).

25-04-2019

Cell

Widespread and Functional RNA Circularization in Localized Prostate Cancer.

07-02-2019

The Journal of pathology

Consensus molecular subtype classification of colorectal adenomas.

01-11-2018

Cancer prevention research (Philadelphia, Pa.)

Evaluation of Cancer-Associated DNA Copy Number Events in Colorectal (Advanced) Adenomas.

01-07-2018

Oncotarget

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer.

29-06-2018

Scientific reports

Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer.

14-05-2018

The British journal of surgery

Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.

01-01-2018

Annals of internal medicine

Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.

19-12-2017

F1000Research

Systematically linking tranSMART, Galaxy and EGA for reusing human translational research data.

11-11-2017

Molecular & cellular proteomics : MCP

Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.

01-10-2017

Science translational medicine

Direct detection of early-stage cancers using circulating tumor DNA.

16-08-2017

F1000Research

GeneBreak: detection of recurrent DNA copy number aberration-associated chromosomal breakpoints within genes.

20-07-2017

PloS one

Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.

10-05-2017

British journal of cancer

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.

06-12-2016

Oncotarget

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.

08-11-2016

Oncogene

Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion.

06-10-2016

Oncogene

CFTR is a tumor suppressor gene in murine and human intestinal cancer.

11-08-2016

The British journal of radiology

The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis.

01-07-2016

Cancer informatics

The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care.

28-06-2016

International journal of cancer

Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.

01-03-2016

Oncotarget

A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.

12-01-2016

Nuclear medicine and biology

Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).

01-01-2016

Oncotarget

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.

22-09-2015

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Microsimulation Model For The Assessment Of Personalized Cancer Care: The Mapcca Model Framework.

01-11-2014

Journal of the National Cancer Institute

Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome.

03-10-2001

Cancer research

High frequency of interactions between lung cancer susceptibility genes in the mouse: mapping of Sluc5 to Sluc14.

01-11-1998

Experimental lung research

Genetics of quantitative and qualitative aspects of lung tumorigenesis in the mouse: multiple interacting Susceptibility to lung cancer (Sluc) genes with large effects.

11-07-1998

Nature genetics

Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse.

01-12-1996

Cancer research

A gene for susceptibility to small intestinal cancer, ssic1, maps to the distal part of mouse chromosome 4.

15-07-1995

Immunogenetics

A susceptibility gene for alveolar lung tumors in the mouse maps between Hsp70.3 and G7 within the H2 complex.

01-01-1995

Oncogene

Kras-2 alleles, mutations, and lung tumor susceptibility in the mouse--an evaluation.

01-05-1994